Literature DB >> 29565091

Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.

Konda Reddy Karnati1, Yixuan Wang1.   

Abstract

Two widely used anticancer drugs, doxorubicin (DOX) and paclitaxel (PTX), possess distinct physical properties and chemotherapy specificity. In order to investigate their interaction mechanism with single-walled carbon nanotubes (SWCNTs), co-loading and releasing from the SWCNTs, all-atom molecular dynamics (MD) simulations were firstly carried out for different SWCNT systems, followed by binding free energy calculation with MM-PBSA. The results indicate that the co-loading of DOX and PTX onto the pristine SWCNT is exothermic and spontaneous. The DOX molecules predominantly interact with the SWCNT via π-π stacking through the conjugated aromatic rings, while the separated aromatic rings of PTX also primarily interact with the SWCNT through π-π stacking yet supplemented by an X-π (X = C-H, N-H and C[double bond, length as m-dash]O) interaction. Moreover, the strongest binding of DOX and PTX with the pristine SWCNT shows similar strength (ΔG: -32.0 vs. -33.8 kcal mol-1). For the chitosan functionalized SWCNT (f-SWCNT), the DOX and PTX molecules still prefer binding to the sidewall of the CNT rather than binding with the polymer, and the non-covalent functionalization of the SWCNT with chitosan decreases the binding of DOX and PTX with the sidewall of the f-SWCNT as compared with the DOX/PTX-SWCNT system (ΔG: -24.0 and -21.9 kcal mol-1). The protonation of chitosan and drug molecules further weakens the interaction between DOX/PTX and the f-SWCNT, and shows a consequent displacement of the drug molecules, triggering the release of the drugs. The variation of binding strength of the three systems (DOX/PTX-SWCNT, DOX/PTX-f-SWCNT, and DOXH+/PTXH+-f-SWCNT) was also discussed in terms of the histogram or frequency of the distance from the drugs to the SWCNT. In addition, the encapsulation of two DOX molecules by the f-SWCNT is considerably stronger than the binding of the other six drug molecules to the sidewall, indicating that the encapsulation of anticancer drugs may also play a very important role and should be considered in the drug delivery.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29565091      PMCID: PMC5898243          DOI: 10.1039/C8CP00124C

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  30 in total

Review 1.  Biomedical applications of functionalised carbon nanotubes.

Authors:  Alberto Bianco; Kostas Kostarelos; Charalambos D Partidos; Maurizio Prato
Journal:  Chem Commun (Camb)       Date:  2004-12-21       Impact factor: 6.222

Review 2.  Targeting carbon nanotubes against cancer.

Authors:  Chiara Fabbro; Hanene Ali-Boucetta; Tatiana Da Ros; Kostas Kostarelos; Alberto Bianco; Maurizio Prato
Journal:  Chem Commun (Camb)       Date:  2012-03-19       Impact factor: 6.222

3.  Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.

Authors:  Mengjie Rui; Yuanrong Xin; Ran Li; Yanru Ge; Chunlai Feng; Ximing Xu
Journal:  Mol Pharm       Date:  2016-12-16       Impact factor: 4.939

4.  Revealing noncovalent interactions.

Authors:  Erin R Johnson; Shahar Keinan; Paula Mori-Sánchez; Julia Contreras-García; Aron J Cohen; Weitao Yang
Journal:  J Am Chem Soc       Date:  2010-05-12       Impact factor: 15.419

5.  Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.

Authors:  Chee Leng Lay; Hui Qi Liu; Hui Ru Tan; Ye Liu
Journal:  Nanotechnology       Date:  2010-01-08       Impact factor: 3.874

6.  Coadsorption of Doxorubicin and Selected Dyes on Carbon Nanotubes. Theoretical Investigation of Potential Application as a pH-Controlled Drug Delivery System.

Authors:  Tomasz Panczyk; Pawel Wolski; Leszek Lajtar
Journal:  Langmuir       Date:  2016-05-09       Impact factor: 3.882

7.  Highly efficient individual dispersion of single-walled carbon nanotubes using biocompatible dispersant.

Authors:  Choolakadavil Khalid Najeeb; Jae-Hyeok Lee; Jae-Ho Kim; Duckjong Kim
Journal:  Colloids Surf B Biointerfaces       Date:  2012-08-19       Impact factor: 5.268

Review 8.  Anthracycline and anthraquinone anticancer agents: current status and recent developments.

Authors:  J W Lown
Journal:  Pharmacol Ther       Date:  1993-11       Impact factor: 12.310

9.  Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.

Authors:  Kasturi Muthoosamy; Ibrahim Babangida Abubakar; Renu Geetha Bai; Hwei-San Loh; Sivakumar Manickam
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

Review 10.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

View more
  10 in total

Review 1.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

2.  Modified gaphene oxide (GO) particles in peptide hydrogels: a hybrid system enabling scheduled delivery of synergistic combinations of chemotherapeutics.

Authors:  John D Schneible; Kaihang Shi; Ashlyn T Young; Srivatsan Ramesh; Nanfei He; Clay E Dowdey; Jean Marie Dubnansky; Radina L Lilova; Wei Gao; Erik Santiso; Michael Daniele; Stefano Menegatti
Journal:  J Mater Chem B       Date:  2020-05-06       Impact factor: 6.331

3.  Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer.

Authors:  Ning Suo; Muwen Wang; Yang Jin; Jun Ding; Xueping Gao; Xiaoliang Sun; Haiyang Zhang; Meng Cui; Jilu Zheng; Nianlu Li; Xunbo Jin; Shaobo Jiang
Journal:  Int J Nanomedicine       Date:  2019-02-15

4.  Novel pH-responsive nanohybrid for simultaneous delivery of doxorubicin and paclitaxel: an in-silico insight.

Authors:  Ehsan Alimohammadi; Reza Maleki; Hossein Akbarialiabad; Mohammad Dahri
Journal:  BMC Chem       Date:  2021-02-11

Review 5.  Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery.

Authors:  Alex Bunker; Tomasz Róg
Journal:  Front Mol Biosci       Date:  2020-11-25

6.  Molecular dynamics simulation study of doxorubicin adsorption on functionalized carbon nanotubes with folic acid and tryptophan.

Authors:  Tahereh Arabian; Sepideh Amjad-Iranagh; Rouein Halladj
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

7.  Development and evaluation of a pH-responsive and water-soluble drug delivery system based on smart polymer coating of graphene nanosheets: an in silico study.

Authors:  Abutaleb Alinejad; Heidar Raissi; Hassan Hashemzadeh
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

8.  Fullerene Derivatives (CN-[OH]β) and Single-Walled Carbon Nanotubes Modelled as Transporters for Doxorubicin Drug in Cancer Therapy.

Authors:  Hakim Al Garalleh
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

Review 9.  Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review.

Authors:  Cancan Jin; Kankai Wang; Anthony Oppong-Gyebi; Jiangnan Hu
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

10.  Loading and release of cancer chemotherapy drugs utilizing simultaneous temperature and pH-responsive nanohybrid.

Authors:  Mohammad Dahri; Hossein Akbarialiabad; Ahmad Miri Jahromi; Reza Maleki
Journal:  BMC Pharmacol Toxicol       Date:  2021-07-14       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.